Patrick W. Trown

2.4k total citations
40 papers, 1.9k citations indexed

About

Patrick W. Trown is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Patrick W. Trown has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Immunology and 7 papers in Oncology. Recurrent topics in Patrick W. Trown's work include Virus-based gene therapy research (4 papers), Synthesis and biological activity (4 papers) and Retinoids in leukemia and cellular processes (4 papers). Patrick W. Trown is often cited by papers focused on Virus-based gene therapy research (4 papers), Synthesis and biological activity (4 papers) and Retinoids in leukemia and cellular processes (4 papers). Patrick W. Trown collaborates with scholars based in United States, South Korea and Switzerland. Patrick W. Trown's co-authors include Jorge R. Quesada, David A. Swanson, Adan Rios, J. U. Gutterman, Jordan U. Gutterman, Alicia V. Palleroni, Michael J. Holman, Alan F. Cook, Sandra J. Horning and Raymond Alexanian and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Patrick W. Trown

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick W. Trown United States 24 722 499 475 228 219 40 1.9k
W. Schüler Switzerland 29 1.0k 1.4× 564 1.1× 992 2.1× 252 1.1× 181 0.8× 68 3.0k
S.S. Kerwar United States 27 1.0k 1.4× 567 1.1× 704 1.5× 186 0.8× 128 0.6× 96 2.7k
H. Stähelin Japan 17 1.1k 1.5× 359 0.7× 569 1.2× 233 1.0× 129 0.6× 30 2.7k
J. George Bekesi United States 25 708 1.0× 258 0.5× 554 1.2× 198 0.9× 115 0.5× 96 1.9k
K. Tsukamoto Japan 19 738 1.0× 208 0.4× 445 0.9× 160 0.7× 168 0.8× 50 1.7k
Enrico Mihich United States 29 1.1k 1.5× 950 1.9× 1.2k 2.5× 128 0.6× 178 0.8× 193 2.9k
Ganesh M. Sathe United States 28 1.9k 2.6× 521 1.0× 614 1.3× 275 1.2× 225 1.0× 56 3.3k
Ilona Nakoinz United States 24 906 1.3× 337 0.7× 1.2k 2.5× 214 0.9× 230 1.1× 35 2.4k
Liliane Gattegno France 27 833 1.2× 407 0.8× 475 1.0× 296 1.3× 132 0.6× 87 2.2k
Ronald P. McCaffrey United States 26 856 1.2× 235 0.5× 444 0.9× 263 1.2× 143 0.7× 59 2.6k

Countries citing papers authored by Patrick W. Trown

Since Specialization
Citations

This map shows the geographic impact of Patrick W. Trown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick W. Trown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick W. Trown more than expected).

Fields of papers citing papers by Patrick W. Trown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick W. Trown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick W. Trown. The network helps show where Patrick W. Trown may publish in the future.

Co-authorship network of co-authors of Patrick W. Trown

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick W. Trown. A scholar is included among the top collaborators of Patrick W. Trown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick W. Trown. Patrick W. Trown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hwang, Tae-Ho, Hyuk-Chan Kwon, Kelly Speth, et al.. (2007). A phase I-II clinical trial with JX-594, a targeted and GM-CSF-armed oncolytic poxvirus, by intratumoral injection in patients with liver tumors. Molecular Cancer Therapeutics. 6. 5 indexed citations
3.
Johnson, Leisa, et al.. (2001). Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region. Gene Therapy. 8(15). 1123–1131. 81 indexed citations
4.
White, Mark, et al.. (1994). Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISA. Journal of Immunological Methods. 167(1-2). 227–235. 37 indexed citations
5.
Trown, Patrick W., et al.. (1991). Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chain.. PubMed. 51(16). 4219–25. 25 indexed citations
6.
Itri, Loretta M., Marilyn Campion, Alicia V. Palleroni, et al.. (1987). Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection. Cancer. 59(S3). 668–674. 90 indexed citations
7.
Palleroni, Alicia V. & Patrick W. Trown. (1986). A Sensitive Radioimmunoassay for Detection of Antibodies to Recombinant Human Interferon-αA. Journal of Interferon Research. 6(6). 705–712. 3 indexed citations
8.
Trown, Patrick W., et al.. (1986). Pharmacokinetics and Tissue Distribution of Recombinant Human Alpha A, D, A/D(Bgl), and I Interferons and Mouse Alpha-Interferon in Mice. Journal of Interferon Research. 6(3). 207–213. 22 indexed citations
9.
Collins, Jerry M., Riccardo Riccardi, Patrick W. Trown, Dondra O'Neill, & David G. Poplack. (1985). Plasma and Cerebrospinal Fluid Pharmacokinetics of Recombinant Interferon Alpha A in Monkeys: Comparison of Intravenous, Intramuscular, and Intraventricular Delivery. PubMed. 2(4). 247–253. 37 indexed citations
10.
Krämer, Michael, et al.. (1983). Cell and Virus Sensitivity Studies with Recombinant Human Alpha Interferons. Journal of Interferon Research. 3(4). 425–435. 61 indexed citations
11.
Gutterman, Jordan U., Jorge R. Quesada, Sandra J. Horning, et al.. (1982). Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients. Annals of Internal Medicine. 96(5). 549–556. 293 indexed citations
12.
Beskid, G., James G. Christenson, Roy Cleeland, W. F. DeLorenzo, & Patrick W. Trown. (1981). In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin. Antimicrobial Agents and Chemotherapy. 20(2). 159–167. 34 indexed citations
13.
Cook, Alan F., et al.. (1979). Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosides. Journal of Medicinal Chemistry. 22(11). 1330–1335. 103 indexed citations
14.
Krämer, Michael, et al.. (1979). 5'-deoxy-5-fluorouridine-a New orally active antitumor agent. Comparative activity with 5-fluorouracil, 2'- deoxy-5-fluorouridine and ftorafur against transplant- able tumors in mice and rats. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 20. 12 indexed citations
15.
Pawson, Beverly A., Ruirui Han, Patrick W. Trown, et al.. (1977). ChemInform Abstract: DIHYDRORETINOIC ACIDS AND THEIR DERIVATIVES. SYNTHESIS AND BIOLOGICAL ACTIVITY. Chemischer Informationsdienst. 8(43). 4 indexed citations
16.
Shapiro, Stanley S., et al.. (1976). Effect of aromatic retinoids on rat chondrosarcoma glycosaminoglycan biosynthesis.. PubMed. 36(10). 3702–6. 12 indexed citations
17.
Trown, Patrick W., et al.. (1973). Recognition of template RNA by Qβ polymerase: Sequence at the 3′-terminus of Qβ 6S RNA. Archives of Biochemistry and Biophysics. 154(1). 250–262. 3 indexed citations
18.
Trown, Patrick W., et al.. (1969). Toxic Properties of a Synthetic Double-stranded RNA: Pyrogenicity of Poly I.Poly C in Rabbits. Nature. 223(5207). 717–718. 81 indexed citations
19.
Trown, Patrick W., et al.. (1968). Specific Inhibition of Viral Ribonucleic Acid Replication by Gliotoxin. Science. 159(3813). 431–432. 60 indexed citations
20.
Brown, B. R., et al.. (1961). 478. 4-Substituted steroids derived by rearrangement and reduction of cholestenone enol acetate. Journal of the Chemical Society (Resumed). 2478–2478. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Schüler Breakdown of academic impact, for papers by S.S. Kerwar Breakdown of academic impact, for papers by H. Stähelin Breakdown of academic impact, for papers by J. George Bekesi Breakdown of academic impact, for papers by K. Tsukamoto Breakdown of academic impact, for papers by Enrico Mihich Breakdown of academic impact, for papers by Ganesh M. Sathe Breakdown of academic impact, for papers by Ilona Nakoinz Breakdown of academic impact, for papers by Liliane Gattegno Breakdown of academic impact, for papers by Ronald P. McCaffrey
Rankless by CCL
2026